In an interview with the news service Biostock, Chordate Medical’s CEO Anders Weilandt talks about ongoing market introductions around Europe, the market potential and the strategy going forward.
“During the many trips my colleagues and I have made recently to different countries and meetings in the field of migraines, I encounter everywhere a genuine interest from doctors in the clinical reality. I see in the response how significant our treatment method potentially could be on a global level”, says Anders Weilandt in the interview.
